Wanjia Group Holdings Limited

401 KYG9431A1186

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 am EDT			5-day change	1st Jan Change
0.09 ^HKD	-.--%		+26.76%	+5.88%

Apr. 30	Wanjia Group Holdings Limited Announces Resignation of Ho Man as Independent Non-Executive Director and Committees	CI
2023	Wanjia Group Holdings Incurs Wider Loss in Fiscal H1	MT

Wanjia Group Holdings Limited Announces Resignation of Weng Jiaxing as Executive Director, Effective on November 21, 2014

November 24, 2014 at 06:11 am EST

Wanjia Group Holdings Limited announced that Weng Jiaxing, Executive Director has resigned. The effective date is November 21, 2014.

Latest news about Wanjia Group Holdings Limited

Wanjia Group Holdings Limited Announces Resignation of Ho Man as Independent Non-Executive Director and Committees	Apr. 30	CI
Wanjia Group Holdings Incurs Wider Loss in Fiscal H1	Nov. 28	MT
Wanjia Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 27	CI
Wanjia Group Swings to Profit in FY23 on Higher Revenue	23-06-26	MT
Wanjia Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-26	CI
Wanjia Group Holdings Sees Return to Profit in FY23	23-06-26	MT
Wanjia Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023	23-06-23	CI
Wanjia Group Swings to $320,600 For Six-Month Period	22-11-23	MT
Wanjia Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-23	CI
Wanjia Group Unit Terminates Agreement with Zhuhai Jiulong Hospital	22-11-16	MT
Wanjia Group Forecasts Increased April-Sept Loss	22-11-09	MT
Wanjia Group Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2022	22-11-09	CI
Wanjia Group Holdings Limited Announces Change of Registered Office and Address Of Principal Share Registrar and Transfer Office	22-09-30	CI
Wanjia Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-27	CI
Wanjia Group Sees Higher FY22 Net Loss	22-06-16	MT
Wanjia Group Turns to Fiscal H1 Profit as Hemodialysis Business Revenue Surges; Shares Drop 6%	21-11-22	MT
Wanjia Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-22	CI
Wanjia Group Issues Update on Swing to Profit Outlook for Fiscal H1	21-11-01	MT
Wanjia Group Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2021	21-11-01	CI
Wanjia Group to Swing to Profit in Fiscal H1; Shares Rally 9%	21-10-28	MT
Wanjia Group Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2021	21-10-27	CI
Wanjia Group Holdings Limited Announces Executive Changes	21-10-15	CI
Wanjia : Attributable Loss Narrows in Fiscal Year 2021	21-06-29	MT
Wanjia Group Holdings Limited Announces Audited Consolidated Earnings Results for the Year Ended March 31, 2021	21-06-28	CI
Wanjia : Posts Narrow Loss for Fiscal H1	20-11-22	MT

Chart Wanjia Group Holdings Limited

Duration

Period

More charts

Wanjia Group Holdings Ltd is an investment holding company principally engaged in the pharmaceutical wholesale and distribution business, and hemodialysis treatment and consultancy service business. The Company mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.

Sector

Healthcare Facilities & Services

Calendar

2024-06-23 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
WANJIA GROUP HOLDINGS LIMITED	+5.88%	6.45M
HCA HEALTHCARE, INC.	+25.52%	88.99B
CVS HEALTH CORPORATION	-24.52%	74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-5.56%	25.03B
FRESENIUS SE & CO. KGAA	+4.31%	17.88B
LABCORP HOLDINGS INC.	-14.25%	16.43B
QUEST DIAGNOSTICS INCORPORATED	+2.97%	15.77B
TENET HEALTHCARE CORPORATION	+79.20%	13.21B
NATERA, INC.	+70.11%	13.09B
DAVITA INC.	+40.44%	12.9B

Other Healthcare Facilities & Services